Third French Congress on Mesothelioma
Pleura and Peritoneum · 08.07.2026 · 11 (2) · 89-98
DOI: 10.1515/pp-2026-0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pleura and Peritoneum, online erschienen am 06.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Well-characterized tumor associated antigens (TAA) represent targets of interest in many anti-cancer therapeutic strategies.In this study, we aimed at developing Affitins directed against human mesothelin (hMSLN).Affitins are a type of small (7 kDa), thermostable and high affinity non-immunoglobulin protein scaffolds derived from Archaea.hMSLN is a TAA overexpressed in pleural mesothelioma (PM) that has been targeted in numerous clinical trials in recent years. METHODSRibosome display and next generation sequencing were used to identify hMSLN-specific Affitins.Surface Plasmon Resonance (SPR) and NanoDSF allowed to determine affinity and thermal stability, respectively.hMSLN-expressing and -negative cells were used in 2D and 3D models, under static or flow conditions.Flow cytometry and confocal microscopy were used to characterize Affitins binding properties on cells.NK92hCD16 cells were used to evaluate anti-tumor activity of BiKE on 2D and 3D PM models. RESULTSWe isolated several Affitins specific for hMSLN.The homodimerization of the most promising Affitin (N13) allowed to improve affinity by 60 (from 35 nM to 0.57 nM).This Affitin, monomeric or dimeric, was highly specific and also stable under a wide range of temperatures and upon repeated freeze/thaw cycles.Finally, Bispecific natural killer (NK) cell Engagers (BiKE) composed of an anti-CD16 VHH fused to N13 Affitins (monomeric or dimeric) were constructed.We showed the specific lysis of hMSLN expressing cells in the presence of BiKE and NK cells. CONCLUSIONThanks to their advantageous properties, Affitins appear as promising affinity agent for the design of BiKEs with potential therapeutic application.
Zitieren
APA
(2026). Third French Congress on Mesothelioma. Pleura and Peritoneum, 11(2), 89-98. https://doi.org/10.1515/pp-2026-0013
Vancouver
Third French Congress on Mesothelioma. Pleura and Peritoneum. 2026;11(2):89-98. doi:10.1515/pp-2026-0013
BibTeX
@article{euvimed2026,
title = {Third French Congress on Mesothelioma},
journal = {Pleura and Peritoneum},
year = {2026},
volume = {11},
number = {2},
pages = {89--98},
doi = {10.1515/pp-2026-0013}
}
EUVIMED